Abstract
There have been considerable advances in understanding the metabolic role of the endothelial lining cells of the blood vessels. Angiotensin-converting enzyme activity is concentrated in these cells, especially those lining the pulmonary circulation. The enzyme exerts control over systemic vascular tone indirectly through the powerful pressor effect of angiotensin II. A number of therapeutic agents are now available which directly inhibit converting enzyme activity and thereby effect a reduction in blood pressure. Macrophages are the source of increased angiotensin-converting enzyme activity commonly found in association with active sarcoidosis. A better understanding of this phenomenon may give fresh insight into this puzzling condition. Pulmonary endothelial metabolism is affected by lung injury and it is likely that in this situation changing activities of serum angiotensin converting enzyme may indicate the extent of damage and the response to therapy. The full clinical significance of serum ACE measurements has yet to be established. However, raised activities have been reported in a number of other conditions and diabetes mellitus and hyperthyroidism are of particular current interest. The numerous methods and reference ranges described in the literature for the measurement of serum ACE activity require further assessment, and there is a clear need for an accepted reference method.
Full text
PDF![938](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd12/498427/861024969e25/jclinpath00513-0102.png)
![939](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd12/498427/da2cd1a6ed51/jclinpath00513-0103.png)
![940](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd12/498427/a516d87fc1fb/jclinpath00513-0104.png)
![941](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd12/498427/f07de2f8355d/jclinpath00513-0105.png)
![942](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd12/498427/331c3eb08706/jclinpath00513-0106.png)
![943](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd12/498427/805e7065f9e0/jclinpath00513-0107.png)
![944](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd12/498427/177aaf8ba4dc/jclinpath00513-0108.png)
![945](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd12/498427/9dd61a67e7b1/jclinpath00513-0109.png)
![946](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd12/498427/7ef838e373f3/jclinpath00513-0110.png)
![947](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd12/498427/4e2b65c131b8/jclinpath00513-0111.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aiken J. W., Vane J. R. Inhibition of converting enzyme of the renin-angiotensin system in kidneys and hindlegs of dogs. Circ Res. 1972 Mar;30(3):263–273. doi: 10.1161/01.res.30.3.263. [DOI] [PubMed] [Google Scholar]
- Ashutosh K., Keighley J. F. Diagnostic value of serum angiotensin converting enzyme activity in lung diseases. Thorax. 1976 Oct;31(5):552–557. doi: 10.1136/thx.31.5.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Atlas S. A., Case D. B. Renin in essential hypertension. Clin Endocrinol Metab. 1981 Nov;10(3):537–575. doi: 10.1016/s0300-595x(81)80012-6. [DOI] [PubMed] [Google Scholar]
- Baggio B., Favaro S., Cantaro S., Bertazzo L., Frunzio A., Borsatti A. Increased urine angiotensin I converting enzyme activity in patients with upper urinary tract infection. Clin Chim Acta. 1981 Jan 22;109(2):211–218. doi: 10.1016/0009-8981(81)90336-3. [DOI] [PubMed] [Google Scholar]
- Bakhle Y. S. Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung. Nature. 1968 Nov 30;220(5170):919–921. doi: 10.1038/220919a0. [DOI] [PubMed] [Google Scholar]
- Baur X., Fruhmann G., Dahlheim H. Follow-up on angiotensin-converting enzyme in serum of patients with sarcoidosis. Respiration. 1981;41(2):133–138. doi: 10.1159/000194370. [DOI] [PubMed] [Google Scholar]
- Borowsky S. A., Lieberman J., Strome S., Sastre A. Elevation of serum angiotensin-converting enzyme level. Occurrence in alcoholic liver disease. Arch Intern Med. 1982 May;142(5):893–895. [PubMed] [Google Scholar]
- Caldwell P. R., Seegal B. C., Hsu K. C., Das M., Soffer R. L. Angiotensin-converting enzyme: vascular endothelial localization. Science. 1976 Mar 12;191(4231):1050–1051. doi: 10.1126/science.175444. [DOI] [PubMed] [Google Scholar]
- Carmel A., Ehrlich-Rogozinsky S., Yaron A. A fluorimetric assay for angiotensin-I converting enzyme in human serum. Clin Chim Acta. 1979 Apr 16;93(2):215–220. doi: 10.1016/0009-8981(79)90091-3. [DOI] [PubMed] [Google Scholar]
- Case D. B., Wallace J. M., Keim H. J., Weber M. A., Sealey J. E., Laragh J. H. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med. 1977 Mar 24;296(12):641–646. doi: 10.1056/NEJM197703242961201. [DOI] [PubMed] [Google Scholar]
- Chiknas S. G. A liquid chromatography-assisted assay for angiotensin-converting enzyme (peptidyl dipeptidase) in serum. Clin Chem. 1979 Jul;25(7):1259–1262. [PubMed] [Google Scholar]
- Collier J. G., Robinson B. F. Comparison of effects of locally infused angiotensin I and II on hand veins and forearm arteries in man: evidence for converting enzyme activity in limb vessels. Clin Sci Mol Med. 1974 Aug;47(2):189–192. doi: 10.1042/cs0470189. [DOI] [PubMed] [Google Scholar]
- Conroy J. M., Hartley J. L., Soffer R. L. Canine pulmonary angiotensin-converting enzyme. Physicochemical, catalytic and immunological properties. Biochim Biophys Acta. 1978 Jun 9;524(2):403–412. doi: 10.1016/0005-2744(78)90177-8. [DOI] [PubMed] [Google Scholar]
- Cushman D. W., Cheung H. S. Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta. 1971 Oct;250(1):261–265. doi: 10.1016/0005-2744(71)90142-2. [DOI] [PubMed] [Google Scholar]
- Cushman D. W., Cheung H. S., Sabo E. F., Ondetti M. A. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry. 1977 Dec 13;16(25):5484–5491. doi: 10.1021/bi00644a014. [DOI] [PubMed] [Google Scholar]
- Cushman D. W., Cheung H. S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971 Jul;20(7):1637–1648. doi: 10.1016/0006-2952(71)90292-9. [DOI] [PubMed] [Google Scholar]
- Das M., Soffer R. L. Pulmonary angiotensin-converting enzyme. Structural and catalytic properties. J Biol Chem. 1975 Sep 10;250(17):6762–6768. [PubMed] [Google Scholar]
- DeRemee R. A., Rohrbach M. S. Serum angiotensin-converting enzyme activity in evaluating the clinical course of sarcoidosis. Ann Intern Med. 1980 Mar;92(3):361–365. doi: 10.7326/0003-4819-92-3-361. [DOI] [PubMed] [Google Scholar]
- DiSalvo J., Montefusco C. B. Conversion of angiotensin I to angiotensin II in the canine mesenteric circulation. Am J Physiol. 1971 Dec;221(6):1576–1579. doi: 10.1152/ajplegacy.1971.221.6.1576. [DOI] [PubMed] [Google Scholar]
- Dobuler K. J., Catravas J. D., Gillis C. N. Early detection of oxygen-induced lung injury in conscious rabbits. Reduced in vivo activity of angiotensin converting enzyme and removal of 5-hydroxytryptamine. Am Rev Respir Dis. 1982 Sep;126(3):534–539. doi: 10.1164/arrd.1982.126.3.534. [DOI] [PubMed] [Google Scholar]
- Dorer F. E., Kahn J. R., Lentz K. E., Levine M., Skeggs L. T. Hydrolysis of bradykinin by angiotensin-converting enzyme. Circ Res. 1974 Jun;34(6):824–827. doi: 10.1161/01.res.34.6.824. [DOI] [PubMed] [Google Scholar]
- Dorer F. E., Skeggs L. T., Kahn J. R., Lentz K. E., Levine M. Angiotensin converting enzyme: method of assay and partial purification. Anal Biochem. 1970 Jan;33(1):102–113. doi: 10.1016/0003-2697(70)90443-4. [DOI] [PubMed] [Google Scholar]
- FERREIRA S. H. A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA. Br J Pharmacol Chemother. 1965 Feb;24:163–169. doi: 10.1111/j.1476-5381.1965.tb02091.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fanburg B. L., Glazier J. B. Conversion of angiotensin 1 to angiotensin 2 in the isolated perfused dog lung. J Appl Physiol. 1973 Sep;35(3):325–331. doi: 10.1152/jappl.1973.35.3.325. [DOI] [PubMed] [Google Scholar]
- Fanburg B. L., Schoenberger M. D., Bachus B., Snider G. L. Elevated serum angiotensin I converting enzyme in sarcoidosis. Am Rev Respir Dis. 1976 Sep;114(3):525–528. doi: 10.1164/arrd.1976.114.3.525. [DOI] [PubMed] [Google Scholar]
- Favre L., Vallotton M. B., Muller A. F. Relationship between plasma concentrations of angiotensin I, angiotensin II and plasma renin activity during cardio-pulmonary bypass in man. Eur J Clin Invest. 1974 Apr;4(2):135–140. doi: 10.1111/j.1365-2362.1974.tb00384.x. [DOI] [PubMed] [Google Scholar]
- Ferreira S. H., Vane J. R. The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat. Br J Pharmacol Chemother. 1967 Jun;30(2):417–424. doi: 10.1111/j.1476-5381.1967.tb02148.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Franklin W. G., Peach M. J., Gilmore J. P. Evidence for the renal conversion of angiotensin I in the dog. Circ Res. 1970 Sep;27(3):321–324. doi: 10.1161/01.res.27.3.321. [DOI] [PubMed] [Google Scholar]
- Friedland J., Setton C., Silverstein E. Angiotensin converting enzyme: induction by steroids in rabbit alveolar macrophages in culture. Science. 1977 Jul 1;197(4298):64–65. doi: 10.1126/science.194311. [DOI] [PubMed] [Google Scholar]
- Friedland J., Setton C., Silverstein E. Induction of angiotensin converting enzyme in human monocytes in culture. Biochem Biophys Res Commun. 1978 Aug 14;83(3):843–849. doi: 10.1016/0006-291x(78)91471-7. [DOI] [PubMed] [Google Scholar]
- Friedland J., Silverstein E. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol. 1976 Aug;66(2):416–424. doi: 10.1093/ajcp/66.2.416. [DOI] [PubMed] [Google Scholar]
- Friedland J., Silverstein E. Sensitive fluorimetric assay for serum angiotensin-converting enzyme with the natural substrate angiotensin I. Am J Clin Pathol. 1977 Aug;68(2):225–228. doi: 10.1093/ajcp/68.2.225. [DOI] [PubMed] [Google Scholar]
- Friedland J., Silverstein E. Similarity in some properties of serum angiotensin converting enzyme from sarcoidosis patients and normal subjects. Biochem Med. 1976 Apr;15(2):178–185. doi: 10.1016/0006-2944(76)90045-4. [DOI] [PubMed] [Google Scholar]
- Gavras H., Brunner H. R., Turini G. A., Kershaw G. R., Tifft C. P., Cuttelod S., Gavras I., Vukovich R. A., McKinstry D. N. Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N Engl J Med. 1978 May 4;298(18):991–995. doi: 10.1056/NEJM197805042981803. [DOI] [PubMed] [Google Scholar]
- Gocke D. J., Gerten J., Sherwood L. M., Laragh J. H. Physiological and pathological variations of plasma angiotensin II in man. Correlation with renin activity and sodium balance. Circ Res. 1969 May;24(5 Suppl):131–148. [PubMed] [Google Scholar]
- Grönhagen-Riska C. Angiotensin-converting enzyme. I. Activity and correlation with serum lysozyme in sarcoidosis, other chest or lymph node diseases and healthy persons. Scand J Respir Dis. 1979 Apr;60(2):83–93. [PubMed] [Google Scholar]
- Hayakari M., Kondo Y., Izumi H. A rapid and simple spectrophotometric assay of angiotensin-converting enzyme. Anal Biochem. 1978 Feb;84(2):361–369. doi: 10.1016/0003-2697(78)90053-2. [DOI] [PubMed] [Google Scholar]
- Hurst P. L., Lovell-Smith C. J. Optimized assay for serum angiotensin-converting enzyme activity. Clin Chem. 1981 Dec;27(12):2048–2052. [PubMed] [Google Scholar]
- James D. G., Neville E., Siltzbach L. E. A worldwide review of sarcoidosis. Ann N Y Acad Sci. 1976;278:321–334. doi: 10.1111/j.1749-6632.1976.tb47043.x. [DOI] [PubMed] [Google Scholar]
- James D. G., Turiaf J., Hosoda Y., Williams W. J., Israel H. L., Douglas A. C., Siltzbach L. E. Description of sarcoidosis: Report of the Subcommittee on Classification and Definition. Ann N Y Acad Sci. 1976;278:742–742. doi: 10.1111/j.1749-6632.1976.tb47090.x. [DOI] [PubMed] [Google Scholar]
- James E. M., Williams W. J. Fine structure and histochemistry of epithelioid cells in sarcoidosis. Thorax. 1974 Jan;29(1):115–120. doi: 10.1136/thx.29.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kamoun P. P., Bardet J. I., Di Giulio S., Grunfeld J. P. Measurements of angiotensin converting enzyme in captopril-treated patients. Clin Chim Acta. 1982 Feb 5;118(2-3):333–336. doi: 10.1016/0009-8981(82)90021-3. [DOI] [PubMed] [Google Scholar]
- Kasahara Y., Ashihara Y. Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem. 1981 Nov;27(11):1922–1925. [PubMed] [Google Scholar]
- Kato H., Suzuki T. Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffi. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and C. Biochemistry. 1971 Mar 16;10(6):972–980. doi: 10.1021/bi00782a007. [DOI] [PubMed] [Google Scholar]
- Lanzillo J. J., Fanburg B. L. Angiotensin I converting enzyme from human plasma. Biochemistry. 1977 Dec 13;16(25):5491–5495. doi: 10.1021/bi00644a015. [DOI] [PubMed] [Google Scholar]
- Leuenberger P. J., Stalcup S. A., Mellins R. B., Greenbaum L. M., Turino G. M. Decrease in angiotensin I conversion by acute hypoxia in dogs. Proc Soc Exp Biol Med. 1978 Sep;158(4):586–589. doi: 10.3181/00379727-158-40252. [DOI] [PubMed] [Google Scholar]
- Lieberman J., Beutler E. Elevation of serum angiotensin-converting enzyme in Gaucher's disease. N Engl J Med. 1976 Jun 24;294(26):1442–1444. doi: 10.1056/NEJM197606242942609. [DOI] [PubMed] [Google Scholar]
- Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975 Sep;59(3):365–372. doi: 10.1016/0002-9343(75)90395-2. [DOI] [PubMed] [Google Scholar]
- Lieberman J., Nosal A., Schlessner A., Sastre-Foken A. Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis. Am Rev Respir Dis. 1979 Aug;120(2):329–335. doi: 10.1164/arrd.1979.120.2.329. [DOI] [PubMed] [Google Scholar]
- Lieberman J., Sastre A. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med. 1980 Dec;93(6):825–826. doi: 10.7326/0003-4819-93-6-825. [DOI] [PubMed] [Google Scholar]
- MacGregor G. A., Markandu N. D., Roulston J. E., Jones J. C. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme. Br Med J. 1979 Nov 3;2(6198):1106–1109. doi: 10.1136/bmj.2.6198.1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Massaro D., Handler A. E., Katz S., Young R. C., Jr Excretion of hydroxyproline in patients with sarcoidosis. Am Rev Respir Dis. 1966 Jun;93(6):929–933. doi: 10.1164/arrd.1966.93.6.929. [DOI] [PubMed] [Google Scholar]
- Milledge J. S., Catley D. M. Renin, aldosterone, and converting enzyme during exercise and acute hypoxia in humans. J Appl Physiol Respir Environ Exerc Physiol. 1982 Feb;52(2):320–323. doi: 10.1152/jappl.1982.52.2.320. [DOI] [PubMed] [Google Scholar]
- Mitchell D. N., Scadding J. G. Sarcoidosis. Am Rev Respir Dis. 1974 Dec;110(6):774–802. doi: 10.1164/arrd.1974.110.6P1.774. [DOI] [PubMed] [Google Scholar]
- Molteni A., Zakheim R. M., Mullis K. B., Mattioli L. The effect of chronic alveolar hypoxia on lung and serum angiotensin I converting enzyme activity. Proc Soc Exp Biol Med. 1974 Oct;147(1):263–265. doi: 10.3181/00379727-147-38323. [DOI] [PubMed] [Google Scholar]
- Mue S., Takahashi M., Ohmi T., Shibahara S., Yamauchi K., Fujimoto S., Okayama H., Takishima T. Serum angiotensin converting enzyme level in bronchial asthma. Ann Allergy. 1978 Jan;40(1):51–57. [PubMed] [Google Scholar]
- NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann Intern Med. 1981 Jan;94(1):73–94. doi: 10.7326/0003-4819-94-1-73. [DOI] [PubMed] [Google Scholar]
- Ng K. K., Vane J. R. Conversion of angiotensin I to angiotensin II. Nature. 1967 Nov 25;216(5117):762–766. doi: 10.1038/216762a0. [DOI] [PubMed] [Google Scholar]
- Ng K. K., Vane J. R. Fate of angiotensin I in the circulation. Nature. 1968 Apr 13;218(5137):144–150. doi: 10.1038/218144a0. [DOI] [PubMed] [Google Scholar]
- Ondetti M. A., Rubin B., Cushman D. W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science. 1977 Apr 22;196(4288):441–444. doi: 10.1126/science.191908. [DOI] [PubMed] [Google Scholar]
- Ondetti M. A., Williams N. J., Sabo E. F., Pluscec J., Weaver E. R., Kocy O. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry. 1971 Oct 26;10(22):4033–4039. doi: 10.1021/bi00798a004. [DOI] [PubMed] [Google Scholar]
- Oparil S., Low J., Koerner T. J. Altered angiotensin I conversion in pulmonary disease. Clin Sci Mol Med. 1976 Dec;51(6):537–543. doi: 10.1042/cs0510537. [DOI] [PubMed] [Google Scholar]
- Oparil S., Sanders C. A., Haber E. In-vivo and in-vitro conversion of angiotensin I to angiotensin II in dog blood. Circ Res. 1970 May;26(5):591–599. doi: 10.1161/01.res.26.5.591. [DOI] [PubMed] [Google Scholar]
- Pascual R. S., Gee J. B., Finch S. C. Usefulness of serum lysozyme measurement in diagnosis and evaluation of sarcoidosis. N Engl J Med. 1973 Nov 15;289(20):1074–1076. doi: 10.1056/NEJM197311152892007. [DOI] [PubMed] [Google Scholar]
- Rodriguez G. E., Shin B. C., Abernathy R. S., Kendig E. L., Jr Serum angiotensin-converting enzyme activity in normal children and in those with sarcoidosis. J Pediatr. 1981 Jul;99(1):68–72. doi: 10.1016/s0022-3476(81)80959-6. [DOI] [PubMed] [Google Scholar]
- Rohrbach M. S. [Glycine-1-14C]hippuryl-L-histidyl-L-leucine: a substrate for the radiochemical assay of angiotensin converting enzyme. Anal Biochem. 1978 Jan;84(1):272–276. doi: 10.1016/0003-2697(78)90510-9. [DOI] [PubMed] [Google Scholar]
- Roulston J. E., MacGregor G. A. The measurement of angiotensin-converting enzyme in subjects receiving captopril. N Engl J Med. 1980 Aug 14;303(7):397–397. doi: 10.1056/NEJM198008143030717. [DOI] [PubMed] [Google Scholar]
- Russo F. S., Persson A. V., Wilson I. B. A fluorogenic substrate for angiotensin-converting enzyme in plasma. Clin Chem. 1978 Sep;24(9):1539–1542. [PubMed] [Google Scholar]
- Ryan J. W., Ryan U. S., Schultz D. R., Whitaker C., Chung A. Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II). Biochem J. 1975 Feb;146(2):497–499. doi: 10.1042/bj1460497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rømer F. K. Angiotensin-converting enzyme in sarcoidosis. Acta Med Scand. 1979;206(1-2):27–30. doi: 10.1111/j.0954-6820.1979.tb13464.x. [DOI] [PubMed] [Google Scholar]
- SKEGGS L. T., Jr, KAHN J. R., SHUMWAY N. P. The preparation and function of the hypertensin-converting enzyme. J Exp Med. 1956 Mar 1;103(3):295–299. doi: 10.1084/jem.103.3.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SKEGGS L. T., Jr, MARSH W. H., KAHN J. R., SHUMWAY N. P. The existence of two forms of hypertensin. J Exp Med. 1954 Mar;99(3):275–282. doi: 10.1084/jem.99.3.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SKEGGS L. T., Jr, MARSH W. H., KAHN J. R., SHUMWAY N. P. The existence of two forms of hypertensin. J Exp Med. 1954 Mar;99(3):275–282. doi: 10.1084/jem.99.3.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Selroos O., Grönhagen-Riska C. Angiotensin converting enzyme. III. Changes in serum level as an indicator of disease activity in untreated sarcoidosis. Scand J Respir Dis. 1979 Dec;60(6):328–336. [PubMed] [Google Scholar]
- Shultz T., Miller W. C., Bedrossian C. W. Clinical application of measurement of angiotensin-converting enzyme level. JAMA. 1979 Aug 3;242(5):439–441. [PubMed] [Google Scholar]
- Silverstein E., Friedland J., Kitt M., Lyons H. A. Increased serum angiotensin converting enzyme activity in sarcoidosis. Isr J Med Sci. 1977 Oct;13(10):995–1000. [PubMed] [Google Scholar]
- Silverstein E., Friedland J., Lyons H. A., Gourin A. Elevation of angiotensin-converting enzyme in granulomatous lymph nodes and serum in sarcoidosis: clinical and possible pathogenic significance. Ann N Y Acad Sci. 1976;278:498–513. doi: 10.1111/j.1749-6632.1976.tb47062.x. [DOI] [PubMed] [Google Scholar]
- Silverstein E., Friedland J., Lyons H. A., Gourin A. Markedly elevated angiotensin converting enzyme in lymph nodes containing non-necrotizing granulomas in sarcoidosis. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2137–2141. doi: 10.1073/pnas.73.6.2137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silverstein E., Friedland J., Lyons H. A. Serum angiotensin converting enzyme in sarcoidosis: clinical significance. Isr J Med Sci. 1977 Oct;13(10):1001–1006. [PubMed] [Google Scholar]
- Silverstein E., Lockerman Z., Friedland J. Serum and lymph-node collagenase in sarcoidosis. Comparison with angiotensin-converting enzyme. Am J Clin Pathol. 1978 Sep;70(3):348–351. doi: 10.1093/ajcp/70.3.348. [DOI] [PubMed] [Google Scholar]
- Soffer R. L. Angiotensin-converting enzyme and the regulation of vasoactive peptides. Annu Rev Biochem. 1976;45:73–94. doi: 10.1146/annurev.bi.45.070176.000445. [DOI] [PubMed] [Google Scholar]
- Soffer R. L., Reza R., Caldwell P. R. Angiotensin-converting enzyme from rabbit pulmonary particles. Proc Natl Acad Sci U S A. 1974 May;71(5):1720–1724. doi: 10.1073/pnas.71.5.1720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stanley P., Biron P. Pressor response to angiotensin I during cardio-pulmonary bypass. Experientia. 1969 Jan 15;25(1):46–47. doi: 10.1007/BF01903886. [DOI] [PubMed] [Google Scholar]
- Stewart J. M., Ferreira S. H., Greene L. J. Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II. Biochem Pharmacol. 1971 Jul;20(7):1557–1567. doi: 10.1016/0006-2952(71)90284-x. [DOI] [PubMed] [Google Scholar]
- Studdy P. R., Bird R., Neville E., James D. G. Biochemical findings in sarcoidosis. J Clin Pathol. 1980 Jun;33(6):528–533. doi: 10.1136/jcp.33.6.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turton C. W., Grundy E., Firth G., Mitchell D., Rigden B. G., Turner-Warwick M. Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis. Thorax. 1979 Feb;34(1):57–62. doi: 10.1136/thx.34.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Werb Z., Gordon S. Secretion of a specific collagenase by stimulated macrophages. J Exp Med. 1975 Aug 1;142(2):346–360. doi: 10.1084/jem.142.2.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yotsumoto H., Imai Y., Kuzuya N., Uchimura H., Matsuzaki F. Increased levels of serum angiotensin-converting enzyme activity in hyperthyroidism. Ann Intern Med. 1982 Mar;96(3):326–328. doi: 10.7326/0003-4819-96-3-326. [DOI] [PubMed] [Google Scholar]
- Zorn S. K., Stevens C. A., Schachter E. N., Gee J. B. The angiotensin converting enzyme in pulmonary sarcoidosis and the relative diagnostic value of serum lysozyme. Lung. 1980;157(2):87–94. doi: 10.1007/BF02713601. [DOI] [PubMed] [Google Scholar]